Document is current

Article History

Received: 20 July 2017

Accepted: 22 August 2018

First Online: 4 September 2018

Authors’ information

: Authors have the following expertise - Participation in UK Department of Health initiatives (e.g. NICE Guidelines, NHS England Clinical Reference Group for Offenders): SY, GG, AF, AL, PA. Past or current employment in ADHD specialist clinical or educational services: SY, BC, EW, PA. Past or current employment in general clinical services but with a special interest in ADHD: GG, PC, EF, AF, JH, AL, SM, PM, SR, JS. Past or current service provision in criminal justice services: SY, GG, PC, AF, JH, AL, SM, PM, EW, PA. ADHD committee membership (e.g. UK Adult ADHD Network, ADHD Foundation, ADHD Europe, European Network of Adult ADHD): SY, GG, BC, EF, JH, PM, JS, EW, PA. Criminal justice committee membership (e.g. National Appropriate Adult Network; expert evidence to a public account committee at the House of Lords/House of Commons): GG, AF. Participation in Position Papers on mental health and/or the criminal justice service for professional bodies (e.g. British Psychological Society, Royal College of Psychiatry, World Psychiatric Association Taskforce): SY, GG, AF, SM. KK is a medical writer who worked with this group on a previous ADHD consensus statement.

: Not applicable.

: Not applicable.

: SY has received honoraria for consultancy, sponsorship for attendance at scientific meetings, educational talks, and/or research awards from Janssen, Lilly, HB Pharma, and/or Shire. PM has received honoraria for consultancy and lectures from Lilly, Shire, and Flynn Pharma. AL has received honoraria for consultancy from Lilly. The remaining authors have no disclosures.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.